Status:
UNKNOWN
Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Cirrhosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Bacterial infections are a frequent complication in liver cirrhosis with a bad prognosis. However, the clinical outcome of cirrhotic patients with serious infections is significantly improved over the...
Detailed Description
Unblinded randomized controlled trial with randomisation stratified by epidemiological class of infection. After obtaining informed consent at enrollment, participants will undergo medical examinatio...
Eligibility Criteria
Inclusion
- cirrhosis
- healthcare infection
- older than 18 years
- agreement to participate
Exclusion
- HIV
- patients underwent to liver transplantation
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2015
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT01820026
Start Date
December 1 2012
End Date
June 1 2015
Last Update
May 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manuela Merli
Rome, Rome, Italy, 00100